首页> 中文期刊> 《中华医学杂志(英文版)》 >Randomized controlled trial of antibiotic prophylaxis regimens for transrectai ultrasound-guided prostate biopsy

Randomized controlled trial of antibiotic prophylaxis regimens for transrectai ultrasound-guided prostate biopsy

         

摘要

Background A prior study showed significant antibioti resistance to quinotone in our poputation.In this study we aimed to evaluate and compare the efficacy of a single versus a combined prophylactic antibiotic regimen before transrectal ultrasound-guided prostate biopsy(TRUGPB).Methods A prospective randomized study was conducted at a university hospital.Patients undergoing TRUGPB were randomized into an amoicillin-clavulanate alone(1mg;one dose before and two doses after biopsy)or an amoxicllin-clavulanate+ciprofloxacin group(250mg;one dose before and two doses after biopsy).Patients were surveyed for infection symptoms by phine on days 3 and 30 after TRUGPB.We defined an infective complication as the iccurrence of symptoms including fever,chills or rigor within 30 days after prostate biopsy,requiring medical treatment or hospitalization,aided by a tertiory-wide etectronic medical record system.Results Between November 2007 and July 2009,367 patients were randomized to either amoxicillin-clavulanate alone or amoxicillin-caavulanate+ciprofloxacin group.The infection rates after TRUGPB were 3.9%in the former group(7 out of 179 patoents)versus 0.53%(1 out of 188 patients)in the latter.Sixty-three percent(5/8)of patients with infective complications needed hospitalization.There was no intensive care unit admission or mortality during the study period.Conclusions Combining prophylactic antibiotics with amoxicllin-clavulanate+soprofloxacin significantly reduced the in cidence of infective complications after TRUGPB.We recommended a combination regimen,especially in centre with high incidence of post-TRUGPB infection.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2012年第14期|2432-2435|共4页
  • 作者单位

    Division of Urology, Department of Surgery, 4/F., Clinical Science Building, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;

    Division of Urology, Department of Surgery, 4/F., Clinical Science Building, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;

    Division of Urology, Department of Surgery, 4/F., Clinical Science Building, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;

    Division of Urology, Department of Surgery, 4/F., Clinical Science Building, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;

    Division of Urology, Department of Surgery, 4/F., Clinical Science Building, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号